A5091641647- Advanced Radiotherapy Techniques
- Radiation Therapy and Dosimetry
- Medical Imaging Techniques and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Glioma Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Brain Metastases and Treatment
- Effects of Radiation Exposure
- Bladder and Urothelial Cancer Treatments
- Radiation Dose and Imaging
- Advanced MRI Techniques and Applications
- Colorectal Cancer Surgical Treatments
- Lung Cancer Treatments and Mutations
- Head and Neck Cancer Studies
- Advanced X-ray and CT Imaging
- Radiopharmaceutical Chemistry and Applications
- Cancer Diagnosis and Treatment
- Medical Imaging and Analysis
- Cancer-related cognitive impairment studies
- Cancer, Hypoxia, and Metabolism
- Childhood Cancer Survivors' Quality of Life
Aarhus University Hospital
2016-2025
Korea Institute of Radiological and Medical Sciences
2024
Soonchunhyang University
2024
Odense University Hospital
2013-2024
University of Southern Denmark
2024
Aarhus University
2011-2024
Centre for Cosmology and Particle Physics Phenomenology
2017-2021
Semmelweis University
2020
Johns Hopkins Hospital
2020
Woodward (United States)
2020
The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival medically inoperable patients with stage I non-small-cell lung cancer (NSCLC) was analyzed in a prospective phase II study.Fifty-seven T1NOMO (70%) and T2N0M0 (30%) were included between August 2003 September 2005 at seven different centers Sweden, Norway, Denmark observed up to 36 months. SBRT delivered 15 Gy times three the 67% isodose planning target volume.Progression-free 3 years 52%. Overall-...
Surgical resection provides long term survival in approximately 30% of patients with colorectal carcinoma (CRC) liver metastases. However, only a limited number CRC-metastases are amendable for surgery. We have tested the effect stereotactic body radiotherapy (SBRT) treatment inoperable CRC-metastases. Sixty-four total 141 (n = 44), lung 12), lymph nodes 3), suprarenal gland 1) or two organs 4) were treated SBRT central dose 15 Gy×3 within 5–8 days. Median follow-up was 4.3 years. After 2...
Purpose To evaluate the prognostic role of soluble CD163 (sCD163) in serum and macrophage infiltration primary melanomas from patients with American Joint Committee on Cancer (AJCC) stage I/II melanoma. The scavenger receptor is associated anti-inflammatory macrophages, it shed their surface. Patients Methods Serum samples 227 melanoma obtained before definitive surgery (baseline) during 5 years follow-up were analyzed for sCD163 by enzyme-linked immunosorbent assay. Excised formalin-fixed,...
Abstract BACKGROUND: Tumor cell and host immune interaction plays a key role in carcinogenesis. Signal transducer activator of transcription 3 (STAT3) is constitutively activated cancer believed to be an important mediator tumor‐induced immunosuppression. This paper aims describe the prognostic impact neutrophil dendritic infiltration primary melanoma association this with STAT3 (pSTAT3) cells. METHODS: Formalin‐fixed, paraffin‐embedded melanomas from 186 stage‐I/II patients surgically...
We reviewed results of SBRT treatment 138 patients with medically inoperable stage I NSCLC treated during 1996–2003 at five different centres in Sweden and Denmark. Mean age was 74 years (range 56–90) 69 men 72 women. delivered using a 3D conformal multifield technique stereotactic body frame. Doses were 30–48 Gy (65% isodose the periphery planning target volume, PTV) 2–4 fractions. Equivalent dose 2 fractions (EQD2) range 50–100 Gy. gross tumour volume (GTV) 39 cm3 (2–436), 101 (11–719)....
Background and purpose. Daily organ motion occurring during the course of radiotherapy in pelvic region leads to uncertainties doses delivered tumour organs at risk. Motion patterns include both volume shape changes, calling for deformable image registration (DIR), approaches involving dose accumulation adaptation. In this study, we tested performance a DIR application contour propagation from treatment planning computed tomography (pCT) repeat cone-beam CTs (CBCTs) set prostate cancer...